These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 13925880)

  • 1. Fibrinogen free of plasminogen as substrate for fibrinolytic assays.
    VIGNAL A; BLATRIX C; STEINBUCH M
    Nature; 1962 Feb; 193():693. PubMed ID: 13925880
    [No Abstract]   [Full Text] [Related]  

  • 2. Preparation of profibrinolysin-free fibrinogen and thrombin from human plasma.
    HINK JH; McDONALD JK
    Nature; 1962 Jun; 194():1080-1. PubMed ID: 13907542
    [No Abstract]   [Full Text] [Related]  

  • 3. Electrochemical processing of fibrinogen modified-graphite surfaces: effect on plasmin generation from adsorbed plasminogen.
    Alfonsi-Hourdin S; Longchamp S; Gallet O; Nigretto JM
    Biomaterials; 2006 Jan; 27(1):52-60. PubMed ID: 16029886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolysis and thrombosis of fibrinogen-modified gold nanoparticles for detection of fibrinolytic-related proteins.
    Jian JW; Chiu WC; Chang HT; Hsu PH; Huang CC
    Anal Chim Acta; 2013 Apr; 774():67-72. PubMed ID: 23567118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QUANTITATIVE ESTIMATION OF UROKINASE AND BACTERIAL PLASMINOGEN ACTIVATORS USING A FIBRIN SUBSTRATE FORMED FROM PLASMINOGEN-FREE FIBRINOGEN.
    ANDERSON AJ
    Biochim Biophys Acta; 1963 Aug; 74():554-7. PubMed ID: 14071603
    [No Abstract]   [Full Text] [Related]  

  • 6. FRACTIONATION AND STANDARDIZATION OF PLASMA FIBRINOLYTIC COMPONENTS.
    MACKAY M
    Br Med Bull; 1964 Sep; 20():189-94. PubMed ID: 14209757
    [No Abstract]   [Full Text] [Related]  

  • 7. [Development and optimization of the methods for determining activity of plasminogen activator inhibitor-1 in plasma].
    Roka-Moĭia IaM; Zhernosiekov DD; Kondratiuk AS; Hrynenko TV
    Ukr Biokhim Zh (1999); 2013; 85(4):111-8. PubMed ID: 24319981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of plasminogen and fibrinogen with model silica glass surfaces: adsorption from plasma and enzymatic activity studies.
    Woodhouse KA; Weitz JI; Brash JL
    J Biomed Mater Res; 1994 Apr; 28(4):407-15. PubMed ID: 8006045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molar concentrations of fibrinolytic components, especially free fibrinolysin, in vivo.
    Nanninga LB
    Thromb Diath Haemorrh; 1975 Apr; 33(2):244-55. PubMed ID: 124474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proactivator-activator system in human plasma fibrinolysis: studies on the synthetic fibrinolytic system composed of functionally pure fibrinogen, plasminogen and proactivator, separated from human plasma].
    Okamoto U
    Nihon Seirigaku Zasshi; 1972 Mar; 34(3):147-55. PubMed ID: 4262660
    [No Abstract]   [Full Text] [Related]  

  • 11. The assay of human plasminogen with casein as substrate.
    DERECHIN M
    Biochem J; 1961 Feb; 78(2):443-8. PubMed ID: 13722014
    [No Abstract]   [Full Text] [Related]  

  • 12. Freeze-dried fibrinogen or fibrinogen in EDTA stimulate the tissue-type plasminogen activator-catalysed conversion of plasminogen to plasmin.
    Haddeland U; Sletten K; Bennick A; Brosstad F
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):575-81. PubMed ID: 7841314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THE ASSESSMENT OF FIBRINOLYTIC ACTIVITY IN THE BLOOD.
    FLUTE PT
    Br Med Bull; 1964 Sep; 20():195-9. PubMed ID: 14209758
    [No Abstract]   [Full Text] [Related]  

  • 14. Study of fibrinogen and plasminogen concentrations in rabbits during anaphylactic shock.
    GANS H; KRIVIT W
    J Lab Clin Med; 1961 Aug; 58():259-67. PubMed ID: 13703370
    [No Abstract]   [Full Text] [Related]  

  • 15. MECHANISM OF HUMAN PLASMINOGEN ACTIVATION BY STREPTOKINASE AND HUMAN PLASMIN.
    BLATT WF; GRAY JL; JENSEN H
    Thromb Diath Haemorrh; 1964 Apr; 11():85-93. PubMed ID: 14167118
    [No Abstract]   [Full Text] [Related]  

  • 16. Profibrinolysin, antifibrinolysin, fibrinogen and urine fibrinolytic factors in the human subject.
    GUEST MM
    J Clin Invest; 1954 Nov; 33(11):1553-9. PubMed ID: 13211809
    [No Abstract]   [Full Text] [Related]  

  • 17. FIBRINOLYTIC SYSTEM IN CERTAIN CONGENITAL AND HEREDITARY HAEMORRHAGIC DISORDERS: A CRITICAL EVALUATION OF THE THEORY OF DYNAMIC HAEMOSTASIS.
    KAMEL K; CUMMING RA; DAVIES SH
    Nature; 1963 Nov; 200():478-9. PubMed ID: 14076740
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinolysis.
    Sherry S
    Annu Rev Med; 1968; 19():247-68. PubMed ID: 4172727
    [No Abstract]   [Full Text] [Related]  

  • 20. THE INHIBITION OF TRASYLOL OF FIBRINOLYTIC ACTIVITY ASSOCIATED WITH CARDIOVASCULAR OPERATIONS.
    TICE DA; WORTH MH; CLAUSS RH; REED GH
    Surg Gynecol Obstet; 1964 Jul; 119():71-4. PubMed ID: 14179354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.